Overexpression of c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach

Journal of the American College of Surgeons

Volumn 182, Issue 1, 1996, Pages 55-59

  Onoda, Naoyoshi ^a   Maeda, Kiyoshi ^a   Chung, Yong Suk ^a   Yano, Yoshihisa ^a   Matsui Yuasa, Isao ^a   Otani, Shuzo ^a   Sowa, Michio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; METASTASIS; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; STOMACH CARCINOMA;

BLOTTING, NORTHERN; CARCINOMA; CASE-CONTROL STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; UP-REGULATION;

EID: 0030070604     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ranzani, G. N., Pellegata, N. S., Previdere, C., and others. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. Cancer Res., 1990, 50: 7811-7814.
2. Nanus, D. M., Kelsen, D. P., Mentle, I. R., and others. Infrequent point mutations of ras oncogene in gastric cancers. Gastroenterology, 1990, 98: 955-960.
3. Yokota, J., Yamamoto, N., Toyoshima, K., and others. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene, 1988, 2: 283-287.
4. Koda, T., Matsushima, S., Sasaki, A., and others, c-myc gene amplification in primary stomach cancer. Jpn. J. Cancer Res. (Gann), 1985, 76: 551-554.
5. Nomura, N., Yamamoto, T., Toyoshima, K., and others. DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer. Jpn. J. Cancer Res. (Gann), 1986, 77: 1188-1192.
6. Shibuya, M., Yokota, J., and Ueyama, Y. Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells. Mol. Cell. Biol., 1985, 5: 414-418.
7. c-myc in benign and malignant gastric epithelia. Br. J. Cancer, 1987, 56: 785-786.
8. Yamamoto, T., Yasui, W., Ochiai, A., and others. Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas.Jpn. J. Cancer Res. (Gann), 1987, 78: 1169-1174.
9. Ninomiya, I., Yonemura, Y., Matsuo, H., and others. Expression of c-myc gene product in gastric carcinoma. Oncology, 1991, 48: 149-153.
10. Rothberg, P. G., Erisman, M. D., Diehl, R. E., and others. Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies. Mol. Cell. Biol., 1984, 4: 1096-1103.
11. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann. Biochem., 1987, 162: 156-159.
12. Sambrook, J., Fritsch, E. F., and Maniatis, T. Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In: Molecular Cloning: a Laboratory Manual. Edited by N. Ford and C. Nolan. 2nd ed., chapt. 7. Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
13. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology. Jpn. J. Surg., 1981, 11: 127-145.
14. Sheiness, D., and Bishop, J. M. DNA and RNA from uninfected vertebrate cells contain nucleotide sequence related to the putative transforming gene of avian myelocytomatosis virus. J. Virol., 1979, 31: 514-521.
15. Kelly, K., Cochran, B. H., Stiles, C. D., and Leder, P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell, 1983, 35: 603-610.
16. Lachman, H., and Skoultchi, A. I. Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature, 1984, 310: 592-594.
17. Stewart, T. A., Pattengale, P. K., and Leder, P. Spontaneous mammary adenocarcinoma in transgenic mice that carry and express MTV/myc fusion genes. Cell, 1984, 38, 627-637.
18. Tsuboi, K., Hirayoshi, K., Takeuchi, K., and others. Expression of the c-myc gene in human gastrointestinal malignancies. Biochem. Biophys. Res. Comm., 1987, 146: 699-704.
19. Zborovskaya, I. B., Spitkovsky, D. D., and Kisseljv, F. L. c-myc expression as a possible prognostic factor in some forms of human cancer. Cancer J., 1988, 2: 134-138.
20. Onoda, N. Gene expression in gastric carcinoma tissues. J. Jpn. Surg. Soc., 1995, 96: 362-369.
21. Tastuta, M., Iishi, H., Baba, M., and others. Expression of c-myc mRNA as an aid in histologic differentiation of adenoma from well differentiated adenocarcinoma in the stomach. Cancer, 1994, 73: 1795-1799.
22. Guillem, J. G., Levy, M. F., Hsieh, L. L., and others. Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer. Mol. Carcinog., 1990, 3: 68-74.
23. Miura, T. Immunohistochemical staining of c-myc p62 oncoprotein in normal colon mucosa, colorectal adenomas, and colorectal carcinomas. J. Jpn. Soc. Colo-Proctol., 1990, 43: 1311-1319.